DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,088 filers reported holding DANAHER CORPORATION in Q2 2016. The put-call ratio across all filers is 0.21 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $103,222,000 | +1.1% | 714,686 | 0.0% | 5.86% | +0.9% |
| Q2 2019 | $102,143,000 | -7.2% | 714,686 | -14.3% | 5.81% | +3.3% |
| Q1 2019 | $110,094,000 | +28.0% | 833,917 | 0.0% | 5.62% | +13.8% |
| Q4 2018 | $85,993,000 | -5.1% | 833,917 | -0.1% | 4.94% | +22.0% |
| Q3 2018 | $90,659,000 | +2.1% | 834,340 | -7.2% | 4.05% | -2.7% |
| Q2 2018 | $88,755,000 | -12.3% | 899,422 | -13.0% | 4.16% | -13.8% |
| Q1 2018 | $101,250,000 | +5.5% | 1,034,119 | 0.0% | 4.83% | +5.6% |
| Q4 2017 | $95,987,000 | +0.2% | 1,034,119 | -7.4% | 4.57% | -2.1% |
| Q3 2017 | $95,800,000 | -7.9% | 1,116,808 | -9.4% | 4.67% | -7.9% |
| Q2 2017 | $104,001,000 | -5.1% | 1,232,382 | -3.8% | 5.07% | -6.0% |
| Q1 2017 | $109,549,000 | +10.0% | 1,280,828 | +0.1% | 5.39% | +3.1% |
| Q4 2016 | $99,635,000 | -3.3% | 1,279,996 | -2.6% | 5.23% | -1.0% |
| Q3 2016 | $103,040,000 | -53.0% | 1,314,465 | -39.4% | 5.28% | -21.2% |
| Q2 2016 | $219,027,000 | – | 2,168,594 | – | 6.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |